Pretax income is the income that a company earns before paying income taxes. The Oncology Institute's pretax income for the
three
months ended in Mar. 2024 was $-19.9 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-73.0 Mil.
The Oncology Institute's pretax margin was -21.01%.
During the past 6 years, The Oncology Institute's highest Pretax Margin was 4.30%. The lowest was -25.63%. And the median was -3.71%.
The Oncology Institute Pre-Tax Income Historical Data
The historical data trend for The Oncology Institute's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of The Oncology Institute's Pre-Tax Income
For the Medical Care Facilities subindustry, The Oncology Institute's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Oncology Institute's Pre-Tax Income Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Oncology Institute's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where The Oncology Institute's Pre-Tax Income falls into.
The Oncology Institute Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
The Oncology Institute's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-73.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Oncology Institute (NAS:TOI) Pre-Tax Income Explanation
The Oncology Institute's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as
During the past 6 years, The Oncology Institute's highest Pretax Margin was 4.30%. The lowest was -25.63%. And the median was -3.71%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Oncology Institute Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of The Oncology Institute's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
The Oncology Institute (The Oncology Institute) Business Description
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TOI has been successfully added to your 